Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8151-8200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05550727
The PorchLight Project
NA
Active, not recruiting
342 participants
Started: Sep 23, 2022 · Completed: Jun 30, 2026
3 conditions
4 sponsors
1 location
NCT05503069
Community Interventions to Improve Breastfeeding
NA
Active, not recruiting
120 participants
Started: Sep 23, 2022 · Completed: Feb 25, 2025
2 conditions
1 sponsor
1 location
NCT06322199
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
N/A
Active, not recruiting
119 participants
Started: Sep 23, 2022 · Completed: Dec 31, 2025
5 conditions
1 sponsor
4 locations
NCT05514132
A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
PHASE1
Active, not recruiting
14 participants
Started: Sep 23, 2022 · Completed: Oct 1, 2025
1 condition
1 sponsor
2 locations
NCT05325866
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
PHASE1/PHASE2
Active, not recruiting
260 participants
Started: Sep 23, 2022 · Completed: Feb 6, 2026
1 condition
1 sponsor
115 locations
NCT05563883
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
N/A
Active, not recruiting
5,000,000 participants
Started: Sep 22, 2022 · Completed: Jan 31, 2030
4 conditions
2 sponsors
1 location
NCT05355792
Multicenter Study to Evaluate the Clinical Outcome of the OmniTaper EV Implant in Single Tooth Restorations
NA
Active, not recruiting
139 participants
Started: Sep 22, 2022 · Completed: Jan 31, 2029
1 condition
1 sponsor
6 locations
NCT05302063
A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Painful Diabetic Peripheral Neuropathy (pDPN)
NA
Active, not recruiting
28 participants
Started: Sep 22, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05608707
APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.
NA
Active, not recruiting
180 participants
Started: Sep 22, 2022 · Completed: Sep 30, 2025
6 conditions
4 sponsors
3 locations
NCT05347212
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
PHASE2
Active, not recruiting
30 participants
Started: Sep 22, 2022 · Completed: Jul 16, 2027
2 conditions
1 sponsor
1 location
NCT05518149
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
PHASE3
Active, not recruiting
840 participants
Started: Sep 22, 2022 · Completed: Apr 25, 2025
1 condition
1 sponsor
224 locations
NCT05431088
A Phase 2/3 Study in Adult and Pediatric Participants With SCD
PHASE2/PHASE3
Active, not recruiting
429 participants
Started: Sep 22, 2022 · Completed: Dec 30, 2032
1 condition
1 sponsor
24 locations
NCT05371093
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
PHASE3
Active, not recruiting
231 participants
Started: Sep 22, 2022 · Completed: Oct 31, 2030
1 condition
1 sponsor
52 locations
NCT05558254
ROBERT® as an Intervention to Enhance Muscle Strength After Spinal Cord Injury
NA
Active, not recruiting
12 participants
Started: Sep 21, 2022 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT05533463
Phase I Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
PHASE1
Active, not recruiting
102 participants
Started: Sep 21, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05380453
Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission
PHASE3
Active, not recruiting
151 participants
Started: Sep 21, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
27 locations
NCT05328180
aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE)
NA
Active, not recruiting
116 participants
Started: Sep 21, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05343481
Efficacy of VTP-300 in Chronic Hepatitis B Infection
PHASE2
Active, not recruiting
120 participants
Started: Sep 21, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
18 locations
NCT05503719
An Absorbable Suture Versus a Non-absorbable Suture in Carpal Tunnel Release, a Randomized Controlled Trial
NA
Active, not recruiting
116 participants
Started: Sep 21, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05422482
A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
PHASE1
Active, not recruiting
12 participants
Started: Sep 20, 2022 · Completed: Jun 30, 2027
2 conditions
1 sponsor
3 locations
NCT05440786
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
PHASE2
Active, not recruiting
45 participants
Started: Sep 20, 2022 · Completed: Sep 30, 2028
2 conditions
1 sponsor
29 locations
NCT05450562
Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
33 participants
Started: Sep 20, 2022 · Completed: Dec 25, 2025
1 condition
1 sponsor
13 locations
NCT05145595
Pain Sensitivity During Puberty
NA
Active, not recruiting
200 participants
Started: Sep 20, 2022 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT05409066
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma
PHASE3
Active, not recruiting
549 participants
Started: Sep 20, 2022 · Completed: Dec 31, 2029
1 condition
2 sponsors
273 locations
NCT06699524
Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid
N/A
Active, not recruiting
122 participants
Started: Sep 20, 2022 · Completed: Dec 20, 2024
1 condition
1 sponsor
1 location
NCT05409989
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
NA
Active, not recruiting
154 participants
Started: Sep 20, 2022 · Completed: Nov 30, 2029
1 condition
1 sponsor
25 locations
NCT05401968
Osteoporosis Patient Education in Denmark
NA
Active, not recruiting
3,132 participants
Started: Sep 19, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05462717
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
PHASE1
Active, not recruiting
222 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
64 locations
NCT05280379
Trained Immunity in Thyroid Carcinoma and Colon Carcinoma
N/A
Active, not recruiting
60 participants
Started: Sep 19, 2022 · Completed: Dec 7, 2025
2 conditions
1 sponsor
1 location
NCT05309421
A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma
PHASE2
Active, not recruiting
17 participants
Started: Sep 19, 2022 · Completed: Mar 30, 2026
2 conditions
2 sponsors
4 locations
NCT07145502
Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes
N/A
Active, not recruiting
76 participants
Started: Sep 19, 2022 · Completed: Sep 19, 2027
3 conditions
1 sponsor
1 location
NCT05242484
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE2
Active, not recruiting
577 participants
Started: Sep 19, 2022 · Completed: Mar 27, 2029
1 condition
1 sponsor
403 locations
NCT05510739
Support for Physical Activity in Everyday Life With Parkinson's Disease
NA
Active, not recruiting
140 participants
Started: Sep 19, 2022 · Completed: Jul 31, 2025
4 conditions
2 sponsors
1 location
NCT05206097
Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol
NA
Active, not recruiting
87 participants
Started: Sep 19, 2022 · Completed: Dec 20, 2024
1 condition
1 sponsor
6 locations
NCT05308641
Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain
NA
Active, not recruiting
400 participants
Started: Sep 18, 2022 · Completed: Dec 7, 2025
1 condition
1 sponsor
1 location
NCT05461170
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
PHASE2
Active, not recruiting
95 participants
Started: Sep 17, 2022 · Completed: Aug 31, 2029
1 condition
1 sponsor
20 locations
NCT05540327
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
PHASE2
Active, not recruiting
379 participants
Started: Sep 16, 2022 · Completed: Aug 12, 2028
1 condition
1 sponsor
122 locations
NCT05548114
Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction
NA
Active, not recruiting
74 participants
Started: Sep 16, 2022 · Completed: Dec 31, 2025
1 condition
6 sponsors
1 location
NCT05020704
EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction
PHASE3
Active, not recruiting
100 participants
Started: Sep 16, 2022 · Completed: Jun 12, 2024
1 condition
2 sponsors
3 locations
NCT05512819
A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan
PHASE3
Active, not recruiting
401 participants
Started: Sep 16, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
11 locations
NCT05555264
Enhancing Internet-delivered Cognitive Behaviour Therapy for Alcohol Misuse
NA
Active, not recruiting
205 participants
Started: Sep 16, 2022 · Completed: Mar 31, 2025
1 condition
3 sponsors
1 location
NCT06294275
A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects
PHASE1
Active, not recruiting
68 participants
Started: Sep 16, 2022 · Completed: Apr 6, 2024
1 condition
1 sponsor
1 location
NCT05466890
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
PHASE2
Active, not recruiting
16 participants
Started: Sep 15, 2022 · Completed: Mar 31, 2025
4 conditions
1 sponsor
14 locations
NCT05520619
Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)
PHASE2
Active, not recruiting
114 participants
Started: Sep 15, 2022 · Completed: Jul 31, 2026
2 conditions
4 sponsors
1 location
NCT05454852
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia
N/A
Active, not recruiting
771 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition
4 sponsors
2 locations
NCT05450692
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
PHASE3
Active, not recruiting
594 participants
Started: Sep 15, 2022 · Completed: Oct 6, 2025
1 condition
2 sponsors
193 locations
NCT05415137
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
PHASE3
Active, not recruiting
268 participants
Started: Sep 15, 2022 · Completed: Aug 31, 2025
1 condition
2 sponsors
91 locations
NCT05067491
Bringing Exposure Therapy to Real-Life Context With Augmented Reality-Dogs (ARET)-Dogs
NA
Active, not recruiting
25 participants
Started: Sep 15, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06211582
Clinical Performances of 3-different Tooth-colored Restorative Materials in Class-II Cavities
NA
Active, not recruiting
47 participants
Started: Sep 15, 2022 · Completed: Mar 20, 2024
1 condition
1 sponsor
1 location
NCT05522504
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
N/A
Active, not recruiting
600 participants
Started: Sep 15, 2022 · Completed: Feb 28, 2025
4 conditions
1 sponsor
1 location
Previous
1
More pages
161
162
163
164
165
166
167
More pages
431
Next